Effect of different synthetic membranes on laboratory parameters and survival in chronic haemodialysis patients

por Kreusser, Wilhelm, Reiermann, Stefanie, Vogelbusch, Gert, Bartual, Josè, Schulze-Lohoff, Eckhard
Publicado no NDT Plus (2010)

A Comparison of Different Algorithms for the Assessment of Cardiovascular Risk in Patients at Waiting List for Kidney Transplantation

por Reuter, Stefan, Reiermann, Stefanie, Malyar, Viola, Schütte-Nütgen, Katharina, Schmidt, Renè, Pavenstädt, Hermann, Reinecke, Holger, Suwelack, Barbara
Publicado no PLoS One (2016)

Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant

por Lenders, Malte, Weidemann, Frank, Kurschat, Christine, Canaan-Kühl, Sima, Duning, Thomas, Stypmann, Jörg, Schmitz, Boris, Reiermann, Stefanie, Krämer, Johannes, Blaschke, Daniela, Wanner, Christoph, Brand, Stefan-Martin, Brand, Eva
Publicado no Orphanet J Rare Dis (2016)

Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch–2-Year Follow-Up

por Lenders, Malte, Canaan-Kühl, Sima, Krämer, Johannes, Duning, Thomas, Reiermann, Stefanie, Sommer, Claudia, Stypmann, Jörg, Blaschke, Daniela, Üçeyler, Nurcan, Hense, Hans-Werner, Brand, Stefan-Martin, Wanner, Christoph, Weidemann, Frank, Brand, Eva
Publicado no J Am Soc Nephrol (2016)

Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction Versus Treatment Switch

por Weidemann, Frank, Krämer, Johannes, Duning, Thomas, Lenders, Malte, Canaan-Kühl, Sima, Krebs, Alice, González, Hans Guerrero, Sommer, Claudia, Üçeyler, Nurcan, Niemann, Markus, Störk, Stefan, Schelleckes, Michael, Reiermann, Stefanie, Stypmann, Jörg, Brand, Stefan-Martin, Wanner, Christoph, Brand, Eva
Publicado em 2014